Filing Details
- Accession Number:
- 0001209191-18-045899
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-08 18:01:12
- Reporting Period:
- 2018-08-06
- Accepted Time:
- 2018-08-08 18:01:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1262104 | Mei Pharma Inc. | MEIP | Pharmaceutical Preparations (2834) | 510407811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1604256 | M David Urso | C/O Mei Pharma, Inc. 3611 Valley Centre Drive, Suite 500 San Diego CA 92130 | Chief Operating Officer & Gc | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-08-06 | 17,764 | $3.75 | 33,606 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2018-08-07 | 9,500 | $3.58 | 24,106 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares withheld by and surrendered to the Issuer on August 6, 2018, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units that vested on August 5, 2018.
- Represents the number of shares sold to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units that vested on August 5, 2018.
- The range of sales prices was $3.5825 to $3.60. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
Billionaire Hedge Funds
